Condition

Stomach Cancer clinical trials and research

• 22Clinical trials
• 8Countries

Newest Stomach Cancer clinical trials

All recruiting trials (22)

• IM-1617 in people with advanced solid cancers

  A first-in-human study will test IM-1617 to see if it is safe and helps treat solid tumors that have spread or cannot be removed.

  Recruiting at 5 sites Phase 1 Immunome, Inc. · New Haven, Connecticut and 4 other locations · NCT07578571

• AI language tools to help tumor care teams write MDT reports

  We will test whether AI language tools can help junior cancer doctors write MDT diagnosis and treatment reports more accurately and faster.

  Recruiting at 2 sites Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Guangzhou, Guangdong and 1 other locations · NCT07504367

• First-in-human testing of 3H-10000 for unresectable or metastatic lung and stomach cancers

  This trial will test whether the experimental drug 3H-10000 is safe and helps adults with unresectable or metastatic lung or stomach cancer.

  Recruiting Phase 1/2 3H Pharmaceuticals Co., Ltd. · Beijing, Beijing Municipality · NCT07354711

• Robotic gastrectomy using a patient-side 5th robotic arm

  This trial will try a new multiport robotic system with an extra patient-side arm for adults with operable stomach cancer to see if the surgery works well and is safe.

  Recruiting Chinese University of Hong Kong · Hong Kong and 1 other locations · NCT07310888

• Ivonescimab plus FOLFOX for advanced HER2-negative stomach and gastroesophageal junction adenocarcinoma

  This study tests whether adding ivonescimab to standard FOLFOX chemotherapy helps people with advanced, HER2-negative stomach or gastroesophageal junction adenocarcinoma as first-line treatment.

  Recruiting at 2 sites Phase 2 Massachusetts General Hospital · Santa Monica, California and 1 other locations · NCT07070466

• 18F-G1 PET/CT to see early immunotherapy response in solid tumors and blood cancers

  We are testing if the 18F-G1 PET/CT scan can help tell early on whether people with solid tumors or blood cancers will respond to immunotherapy.

  Recruiting Peking University First Hospital · Beijing · NCT07039474

• Treatment of advanced cancers using CEA-targeted CAR-T cells

  This study is testing a new type of CAR-T cell treatment for people with advanced cancers that have a specific marker, to see if it is safe and how well it works for those who haven't had success with other treatments.

  Recruiting Phase 1 Zhejiang University · Hangzhou, Zhejiang · NCT06821048

• Imaging method for digestive system cancer using targeted PET scans

  This study is testing a new type of PET scan to see if it can better help doctors find and diagnose cancers in the digestive system.

  Recruiting RenJi Hospital · Shanghai, Shanghai Municipality · NCT06715839

• Using brodalumab to treat immune-related side effects from cancer therapy

  This study is testing if brodalumab can help cancer patients who are having immune-related side effects from their immunotherapy treatment feel better.

  Recruiting Phase 1 Columbia University · New York, New York · NCT06673329

• Combining TIL Therapy and Pembrolizumab for Advanced Stomach and Esophageal Cancer

  This study is testing a new treatment that combines a type of immune therapy using patients' own tumor cells with a drug called Pembrolizumab to see if it helps people with advanced stomach and esophageal cancer.

  Recruiting Phase 1/2 Essen Biotech · Beijing, Beijing Municipality · NCT06532799

• Combination treatment for diffuse gastric cancer using avutometinib and defactinib

  This study is testing a new combination of two oral drugs, avutometinib and defactinib, to see if they can help people with advanced stomach cancer live longer and shrink their tumors after chemotherapy.

  Recruiting Phase 2 Columbia University · New York, New York · NCT06487221

• Analyzing shopping habits to improve early cancer diagnosis

  This study is trying to see if changes in shopping habits can help spot cancer earlier by looking at purchase data from loyalty cards of people recently diagnosed with cancer and those without it.

  Recruiting Imperial College London · London · NCT06447064

• Improving care for Black patients with gastrointestinal cancer

  This study is trying to improve cancer care for Black patients with gastrointestinal cancers by ensuring they get the right tests and treatments while helping us understand the challenges they face.

  Recruiting Case Comprehensive Cancer Center · Cleveland, Ohio · NCT06263088

• Treatment of Taxane-resistant Cancers with Paclitaxel Polymeric Micelles

  This study is testing a new form of chemotherapy called Paclitaxel Polymeric Micelles to see if it can help people with advanced cancers that didn't respond to standard Taxane treatments.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT06199895

• Total neoadjuvant chemotherapy for advanced gastric and gastroesophageal cancer

  This study is testing two different chemotherapy plans for people with advanced stomach cancer to see which one helps them better tolerate treatment and successfully have surgery.

  Recruiting at 2 sites Phase 2/3 Ukrainian Society of Clinical Oncology · Vilnius and 1 other locations · NCT06028737

• Combination treatment for ctDNA positive gastric cancer

  This study is testing a new combination treatment for patients with a specific type of stomach cancer to see if it works better than the usual treatment.

  Recruiting Phase 2 The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT05494060

• KN026 combined with chemotherapy for HER2 positive gastric cancer after first-line treatment failure

  This study is testing if a new treatment called KN026 combined with chemotherapy can help people with HER2-positive advanced gastric cancer who didn't respond to their first treatment.

  Recruiting Phase 2/3 Shanghai JMT-Bio Inc. · Beijing · NCT05427383

• Validation of a blood test for early cancer detection and monitoring

  This study is testing a blood test to see if it can help find different types of cancer early and monitor patients after treatment.

  Recruiting at 3 sites Adela, Inc · Duarte, California and 16 other locations · NCT05366881

• CA-4948 combined with chemotherapy and immunotherapy for advanced gastric and esophageal cancer

  This study is testing a new treatment combining CA-4948 with chemotherapy and immunotherapy to see if it helps people with advanced stomach and esophageal cancer who haven't had other treatments yet.

  Recruiting Phase 1 Washington University School of Medicine · St Louis, Missouri · NCT05187182

• Using virtual reality to help manage pain in GI cancer patients

  This study is testing if virtual reality can help people with GI cancer manage their severe abdominal pain better than standard treatments.

  Recruiting Cedars-Sinai Medical Center · Los Angeles, California · NCT04907643

• Comparing endoscopic resection and surgery for early gastric cancer

  This study is testing if a less invasive procedure called endoscopic submucosal dissection can be as effective and cost-friendly as traditional surgery for people with early gastric cancer.

  Recruiting National Cancer Center, Korea · Goyang-si, Gyeonggi-do · NCT04890171

• Research on upper gastrointestinal cancers using tissue and blood samples

  This study is trying to learn more about gastric and esophageal cancers by looking at tissue and blood samples from patients to find out how genes and proteins affect these diseases.

  Recruiting Stanford University · Stanford, California · NCT01048281

Related topics

Quick answers

How many Stomach Cancer clinical trials are recruiting right now?

22, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 8 countries. The most sites are in China (9 trials), United States (9 trials), Hong Kong (1 trial), Japan (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1: 4, Phase 1/2: 2, Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →